直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

INCONTESTABLE® Blog

Examining Attorneys May Not Rely on ‘Family of Marks’ in Ex Parte Proceedings

February 27, 2014

Authored and Edited by Morgan E. Smith

In a precedential ruling released last Friday, the TTAB made clear that examining attorneys may not rely on a “family of marks” theory in assessing likelihood of confusion for registrability purposes. In re Hitachi High-Techs. Corp., Serial No. 79110412 (TTAB Feb. 21, 2014) [PRECEDENTIAL].

Hitachi High-Technologies Corp. applied to register OPTICROSS for “liquid chromatography apparatus and parts thereof.” The Examining Attorney initially refused registration under Section 2(d), citing a “family” of seven OPTI-formative marks owned by Optimize Technologies. The Examining Attorney subsequently retracted her reference to the OPTI “family of marks,” finding enough evidence to sustain the refusal even without evidence of a “family.”

On appeal, the Board clarified that “[a] ‘family of marks’ may be established in an inter partes proceeding where there is evidence that a group of marks having a shared characteristic are advertised and promoted together.” Mere ownership by a registrant of multiple marks with similar root terms is not enough to establish a “family.” Rather, determination of a family requires consideration of the manner in which the marks are actually used in the marketplace, whether the marks are promoted “as a family” or individually, and their relative degree of distinctiveness. The Board emphasized that reliance on the doctrine in ex parte prosecution is inappropriate because the type of detailed assessment of real-life factors required to establish a “family” of marks is beyond the scope of ex parte proceedings and beyond the resources available to Examining Attorneys. The Board ultimately upheld the refusal of registration on likelihood of confusion grounds.

This decision offers useful insight into the “family of marks” doctrine and the additional burdens of proof that apply to a trademark owner seeking the expanded scope of protection that follows.

Tags

Section 2(d)

Contacts

Morgan E. Smith
Partner
Palo Alto, CA
+1 650 849 6665
Email

Copyright © 2014 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Lecture

Munich Licensing Summer Course 2026

June 18-19, 2026

Munich

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

At the PTAB Blog

Claim Disclaimer Derails Instituted IPR in Freightcar America

May 26, 2026

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP